By 2030, the anti-obesity drug market should reach $95 billion
This review helps determine if Semaglutide fits your unique situation and spots any potential health concerns
The consequences of muscle mass loss during GLP-1-induced weight loss include reduced resting metabolic rate making weight regain more likely if the medication is stopped reduced functional strength and physical capacity, increased falls risk in older adults, reduced bone density, and the loss of the metabolic benefits that muscle tissue provides including improved insulin sensitivity and glucose uptake
Preventive measures and first-line treatments will also be covered, along with more advanced medical interventions for persistent or severe cases
The magnitude of weight loss varies by product: semaglutide 2.4mg (Wegovy) can achieve approximately 15% reduction in body weight, while liraglutide 3mg (Saxenda) typically produces around 8% weight loss
GLP-1 Agonists are popular medications that mimic the way the natural GLP-1 hormone works
.webp?t=1743535811)
